Research-use-only labelling: what it means and what it does not — the long version

Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not — the long version Everything below is what sits behind that.

A labelling question, and I would like the answer to be about what the words mean rather than about what people do.

"Research use only" appears on the vial and on the paperwork. Research-use-only material is not approved for human use in any jurisdiction I am aware of, and I am asking about the classification itself: what it obliges the seller to do, what it obliges the buyer to do, and what it says about the material.

I would rather have the narrow, accurate answer than the broad, comfortable one.

Answering the question the opening post raises rather than the one it answers.

An update on my earlier Research-use-only labelling post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.

Building on the opening post rather than restating it.

Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such claims turn out to rest on a forum post.

Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so.

The claim is narrower than it sounds, and deliberately so.

What I would tell a new member reading about Research-use-only labelling for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

Post #4 is the version of this I will quote in future. One addition.

Distinguishing three things in the Research-use-only labelling discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.

Where I part company with post #7, and it is a narrow parting.

If you can confirm or contradict a position for your own region, please date the answer. An undated regional claim is the least useful thing in this category.

Picking up post #8: that is the part I would want checked first.

Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling tells you the intended use, not the actual use people make of it.

The general case is well covered; this is the awkward specific one.

Research-use-only labelling looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

Research-use-only labelling is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.

The arithmetic in post #9 is right; the assumption feeding it is the part to check.

An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.

This has been discussed before and I could not find the thread, so, again.

One more thing on Research-use-only labelling that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.

Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality.

Reading it again, the caveat matters more than the finding.